Tatiana Koneva

Dr. Tatiana Koneva


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
NGNikolay Goncharov
Nikolay Goncharov
ESElena I. Savelieva
Elena I. Savelieva
TKTatiana Koneva
Tatiana Koneva
LGLyudmila K. Gustyleva
Lyudmila K. Gustyleva
IVIrina Vasileva
Irina Vasileva
RJRichard Jenkins
Richard Jenkins
Background/Objectives: The delayed effects of organophosphate poisoning may manifest years after exposure, often masked by age-related diseases. The aim of this retrospective cohort study was to identify the biochemical “trace” that could remain in patients decades after poisoning. We determined a wide range of biochemical parameters, along with the spectrum of esterified and non-esterified fatty acids (EFAs and NEFAs, respectively), in the blood plasma of a cohort of elderly patients diagnosed with occupational pathology (OP) due to (sub)chronic exposure to organophosphates in the 1980s. Methods: Elderly patients with and without a history of exposure to organophosphates were retrospectively divided into two groups: controls (n = 59, aged 73 ± 4, men 29% and women 71%) and those with OP (n = 84, aged 74 ± 4, men 29% and women 71%). The period of neurological examination and blood sampling for subsequent analysis was from mid-2022 to the end of 2023. Determination of the content of biomarkers of metabolic syndrome, NEFAs, and EFAs in blood plasma was performed by HPLC-MS/MS and GC-MS. Results: The medical histories of the examined elderly individuals with OP and the aged control group included common age-related diseases. However, patients with OP more often had hepatitis, gastrointestinal diseases, polyneuropathy, and an increased BMI. Analysis of metabolic biomarkers revealed, in the OP group, a decrease in the concentrations of 3-hydroxybutyrate (p < 0.05), 2-hydroxybutyrate (p < 0.0001), and acetyl-L-carnitine (p < 0.001) and the activity of butyrylcholinesterase (BChE) (p < 0.05), but an increase in the esterase activity of albumin (p < 0.05). Correlation analysis revealed significant relationships between albumin esterase activity and arachidonic acid concentrations in the OP group (0.64, p < 0.0001). A study of a wide range of fatty acids in patients with OP revealed reciprocal relationships between EFAs and NEFAs. A statistically significant decrease in concentration was shown for esters of margaric, stearic, eicosadienoic, eicosatrienoic, arachidonic, eicosapentaenoic, and docosahexaenoic fatty acids. A statistically significant increase in concentration was shown for non-esterified heptadecenoic, eicosapentaenoic, eicosatrienoic, docosahexaenoic, γ-linolenic, myristic, eicosenoic, arachidonic, eicosadienoic, oleic, linoleic, palmitic, linoelaidic, stearic, palmitoleic, pentadecanoic, and margaric acids. Decreases in the ratios of omega-3 to other unsaturated fatty acids were observed only for the esterified forms. Conclusions: The data obtained allow us to consider an increased level of NEFAs as one of the main cytotoxic factors for the vascular endothelium. Modification of albumin properties and decreased bioavailability of docosahexaenoic acid could be molecular links that cause specific manifestations of organophosphate-induced pathology at late stages after exposure.

12 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NGNikolay Goncharov
Nikolay Goncharov
ESElena I. Savelieva
Elena I. Savelieva
TKTatiana Koneva
Tatiana Koneva
LGLyudmila K. Gustyleva
Lyudmila K. Gustyleva
IVIrina Vasileva
Irina Vasileva
RJRichard Jenkins
Richard Jenkins
Background/Objectives: The delayed effects of subchronic and chronic organophosphate poisoning may manifest years after exposure, often masked by age-related diseases. The aim of this retrospective cohort study was to identify the biochemical "trace" that could remain in the patients decades after the poisoning. To achieve this goal, we determined a wide range of biochemical parameters, along with the spectrum of esterified and non-esterified fatty acids (EFA and NEFA, respectively), in the blood plasma of a cohort of elderly patients diagnosed with occupational pathology (OP) due to subacute or (sub)chronic exposure to organophosphates in the 1980s. Methods: Elderly patients with and without a history of exposure to organophosphates were retrospectively divided into two groups: controls (n=59, aged 73±4, men 29% and women 71%) and having the OP (n=84, aged 74±4, men 29% and women 71%). The period of neurological examination and blood sampling for subsequent analysis was approximately one and a half years - from mid-2022 to the end of 2023. Determination of the content of biomarkers of metabolic syndrome, NEFA and EFA in blood plasma was performed by HPLC-MS/MS and GC-MS. Results: The medical history of the examined elderly individuals with OP and the aged control group includes common age-related diseases. However, patients with OP more often have hepatitis (33 vs 7%, p<0.001) and other gastrointestinal diseases (54 vs 32%, p<0.05), total with diagnosis of polyneuropathy (87 vs 66%, p<0.01) and polyneuropathy of the upper and lower extremities (29 vs 12%, p<0.05), impaired distal sensitivity (83 vs 56%, p<0.001), increased body mass index (30.0±4.6 vs 28.4±4.1, p<0.05), and also they have an increased drug load (5 vs 4, p<0.001). Patients with OP more often have balance problems (84 vs 69%, p<0.05) and difficulties in performing daily activities (75 vs 49%, p<0.01). No differences were found between the groups when assessing cognitive function using the MMSE (mini mental state examination), SAGE (self-administered gerocognitive exam), and “Clock” tests. Of the 34 basic biochemical parameters determined on the biochemical analyzer, statistically significant changes were found for only 11, with their median values not going beyond the reference range (clinical norm), and the differences being due to significant individual deviations. Analysis of some metabolic biomarkers with HPLC-MS/MS revealed in the OP group a 1.4-fold decrease in the concentration of 3-hydroxybutyrate (p<0.05, AUC=0.62) and 1.6-fold decrease in the concentration of 2-hydroxybutyrate (p<0.0001, AUC=0.72). In the OP group, a 26% decrease in acetyl-L-carnitine concentration was found (p<0.001, AUC=0.69). An additional study of the esterase profile of patients revealed a decrease in the activity of butyrylcholinesterase (BChE) by 14% (p<0.05, AUC=0.62) though increase in the esterase activity of albumin by 29% (p<0.05, AUC=0.62) in the OP group. Correlation analysis revealed the most significant relationships between albumin esterase activity and arachidonic acid concentration in the OP group (0.64, p<0.0001). A study of a wide range of fatty acids in patients with OP revealed reciprocal relationships between EFA and NEFA. A decrease in concentration was shown for esters of margaric (p<0.01, AUC=0.65), stearic (p<0.01, AUC=0.65), eicosadienoic (p<0.01, AUC=0.63), eicosatrienoic (p<0.01, AUC=0.66), arachidonic (p<0.001, AUC=0.67), eicosapentaenoic (p<0.05, AUC=0.60), and docosahexaenoic (p<0.0001, AUC=0.74) fatty acids. An increase in the concentration was shown for free (non-esterified) fatty acids: heptadecenoic (p<0.0001, AUC=0.72), eicosapentaenoic (p<0.05, AUC=0.62), eicosatrienoic (p<0.001, AUC=0.68), docosahexaenoic (p<0.01, AUC=0.66), γ-linolenic (p<0.01, AUC=0.66), myristic (p<0.0001, AUC=0.71), eicosenoic (p<0.01, AUC=0.65), arachidonic (p<0.01, AUC=0.66), eicosadienoic (p<0.001, AUC=0.67), oleic (p<0.01, AUC=0.66), linoleic (p<0.01, AUC=0.65), palmitic (p<0.001, AUC=0.68), linoelaidic (p<0.01, AUC=0.65), stearic (p<0.01, AUC=0.64), palmitoleic (p<0.05, AUC=0.61), pentadecanoic (p<0.05, AUC=0.61), and margaric (p<0.01, AUC=0.64). Decrease in the ratios of omega-3 to other unsaturated fatty acids were observed only for the esterified forms: by 29% for n3/n6 (p<0.0001, AUC=0.70), by 33% for n3/(n6+n9) (p<0.0001, AUC=0.72), and by 26% for n3/(all fatty acids) (p<0.0001, AUC=0.72). Finally, we have found out how the most reliable indicators correlate with each other. The esterified docosahexaenoic acid – lactate dehydrogenase (LDH) (0.67, p <0.0001) and LDH – total antioxidant status (TAS) (-0.61, p <0.0001) correlations are stronger in the OP group compared to the correlation in the overall sample and lose their strength and statistical significance in the control group. In the OP group, esterified docosahexaenoic fatty acid, LDH activity, and TAS concentration have a moderate correlation with calcium concentration (-0.66, p <0.0001; -0.67, p <0.0001; 0.63, p <0.0001, respectively). In the control group, this correlation is significantly weakened. Esterified docosahexaenoic acid in the OP group also demonstrated strong positive correlations with a row of other esterified fatty acids, though these correlations were not significantly weakened in the control group. Conclusions: The data obtained allow us to consider an increased level of NEFA as one of the main cytotoxic factors for the vascular endothelium, which can determine the specificity of age-related diseases. Modification of albumin properties by arachidonic acid decreased bioavailability of docosahexaenoic acid could be molecular links that cause specific manifestations of OP-induced pathology at late stages after exposure. Epigenetic changes, the contribution of...

2 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NGNikolay Goncharov
Nikolay Goncharov
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
ARArtem Rubinstein
Artem Rubinstein
TKTatiana Koneva
Tatiana Koneva
NVNatalya Voytenko
Natalya Voytenko
RJRichard Jenkins
Richard Jenkins
The literature describes cases of chronic poisoning by organophosphates: pesticides, flame re-tardants, and other industrial and household chemicals. The delayed effects of acute, subacute, subchronic and chronic poisoning manifest themselves years after exposure, with the effects of the toxic factor eventually masked by age-related diseases with an immunological component. The aim of this study was to investigate the immunological profile of blood cells in a cohort of elderly patients diagnosed with occupational pathology caused by subacute or (sub)chronic ex-posure to organophosphates in the 1980s. Analysis of well-being assessments revealed that patients in the control and organophos-phate-exposed groups had approximately equal levels of memory and thinking impairments, anxiety, melancholy and depression, and cognitive function assessments. However, the organo-phosphate-exposed group experienced significantly more balance and memory impairments, and more pronounced neurological symptoms, manifested by abnormal wrist reflexes, cranio-cerebral changes, impaired vibration and distal sensitivity, and depressed abdominal, ankle and plantar reflexes. The organophosphates-exposed group showed decreased red blood cell counts and hematocrit, white blood cell counts were unchanged in both groups. Lymphocyte phenotyping revealed a 1.5-2-fold increase in the relative and absolute levels of circulating plasma cell precursors with the CD19+IgD–CD27++ phenotype, an absolute count of cells with the CD19+CD27++CD38++ phenotype, and an absolute count of TEMRA CD4+ T cells in the organophosphate-exposed group of patients. However, the proportion of CD56+CD57+ cells of the EM4 (CD27–CD28+) CD8+ T cell subset was more than 2-fold reduced. The identified changes indicate a disruption of immune regulation in elderly people with occu-pational pathology, which along with indicators of the neurological and cognitive status of pa-tients can shed light on the pathogenesis of late pathology and serve as important markers in differential diagnosis.